D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Brain Metabolism during Fasting*

Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,650 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264 · see citing works

Generation of reactive oxygen species by the mitochondrial electron transport chain

Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · see citing works

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010 · see citing works

Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake

Anson, R. M., Guo, Z., de Cabo, R., Iyun, T., Rios, M., Hagepanos, A., Ingram, D. K., Lane, M. A., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035720100 · Cited by 732 · see citing works

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

Teismann, P., Tieu, K., Choi, D., Wu, D., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 659 · see citing works

Origin and functional consequences of the complex I defect in Parkinson's disease

Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638 · see citing works

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Przedborski, S., Jackson-Lewis, V. R., Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624 · see citing works

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Jackson-Lewis, V. R., Jakowec, M. W., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609 · see citing works

ΔΨ _m ‐Dependent and ‐independent production of reactive oxygen species by rat brain mitochondria

Votyakova, T. V., & Reynolds, I. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00548.x · Cited by 601 · see citing works

Control of respiration and ATP synthesis in mammalian mitochondria and cells

Brown, G. C. (1992) · Biochemical Journal · doi:10.1042/bj2840001 · Cited by 598 · see citing works

Series Introduction: Neurodegeneration: What is it and where are we?

Przedborski, S., Vila, M., & Jackson-Lewis, V. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317522 · Cited by 585 · see citing works

d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 531 · see citing works

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

Przedborski, S., Kostić, V., Jackson-Lewis, V. R., Naini, A. B., Simonetti, S., Fahn, S., Carlson, E. J., Epstein, C. J., & Cadet, J. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456 · see citing works

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435 · see citing works

Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.

Ramsay, R. R., & Singer, T. P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57434-8 · Cited by 415 · see citing works

Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism

Mandir, A. S., Przedborski, S., Jackson-Lewis, V., Wang, Z.-Q., Simbulan-Rosenthal, C. M., Smulson, M. E., Hoffman, B. E., Guastella, D. B., Dawson, V. L., & Dawson, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5774 · Cited by 382 · see citing works

Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity

Matthews, R. T., Ferrante, R. J., Klivènyi, P., Yang, L., Klein, A., Mueller, G., Kaddurah-Daouk, R. F., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 374 · see citing works

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

Vila, M., Jackson-Lewis, V. R., Vukosavić, S., Djaldetti, R., Liberatore, G. T., Offen, D., Korsmeyer, S. J., & Przedborski, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633998 · Cited by 372 · see citing works

Complex I and Parkinson's Disease

Greenamyre, J. T., Sherer, T., Betarbet, R. S., & Panov, A. V. (2001) · IUBMB Life · doi:10.1080/15216540152845939 · Cited by 335 · see citing works

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease.

Przedborski, S., & Vila, M. (2003) · PubMed · Cited by 286 · see citing works

The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model

Przedborski, S., & Vila, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07476.x · Cited by 283 · see citing works

IV. MPTP, MPP+ and mitochondrial function

Nicklas, W. J., Youngster, S. K., Kindt, M. V., & Heikkila, R. E. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90299-2 · Cited by 257 · see citing works

Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

Vyas, I. L., Heikkila, R. E., & Nicklas, W. J. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01768.x · Cited by 242 · see citing works

Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain

Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Monte, D. A. D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241 · see citing works

The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism

Rozas, G., López-Martín, M. E., Guerra, M. J., & Labandeira-García, J. L. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00078-8 · Cited by 225 · see citing works

Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in Rat

Brouillet, E., Guyot, M., Mittoux, V., Altairac, S., Condé, F., Palfi, S., & Hantraye, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020794.x · Cited by 210 · see citing works

Is there an astrocyte–neuron ketone body shuttle?

Guzmán, M., & Blázquez, C. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00370-2 · Cited by 208 · see citing works

Control of respiration and oxidative phosphorylation in isolated rat liver cells

Brown, G. C., Lakin‐Thomas, P. L., & Brand, M. D. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19234.x · Cited by 175 · see citing works

Metabolism of Ketone Bodies by the Brain

Sokoloff, L. (1973) · Annual Review of Medicine · doi:10.1146/annurev.me.24.020173.001415 · Cited by 171 · see citing works

5-Hydroxydopamine ‘tagged’ neuronal boutons in rabbit neostriatum: interrelationship between vesicles and axonal membrane

Tennyson, V. M., Heikkila, R. E., Mytilineou, C., COTE, L. J., & Cohen, G. (1974) · Brain Research · doi:10.1016/0006-8993(74)90617-9 · Cited by 155 · see citing works

The hospital and home use of a 30‐second hand‐held blood ketone meter: guidelines for clinical practice

Wallace, T. M., Meston, N. M., Gardner, S. G., & Matthews, D. R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00550.x · Cited by 98 · see citing works

beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices.

Izumi, Y., Ishii, K., Katsuki, H., Benz, A. M., & Zorumski, C. F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1009 · Cited by 95 · see citing works

Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide

Cosi, C., & Marien, M. R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00829-4 · Cited by 87 · see citing works

Amyloid β-Peptide-binding Alcohol Dehydrogenase Is a Component of the Cellular Response to Nutritional Stress

Yan, S. D., Zhu, Y., Stern, E., Hwang, Y. C., Hori, O., Ogawa, S., Frosch, M. P., Connolly, E. S., McTaggart, R., Pinsky, D. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61485-7 · Cited by 56 · see citing works

Quantitative histochemical changes in enzymes involved in energy metabolism in the rat brain during postnatal development. II. Glucose‐6‐phosphate dehydrogenase and β‐hydroxybutyrate dehydrogenase

Bilger, A., & Nehlig, A. (1992) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(92)90042-x · Cited by 28 · see citing works

Developmental regulation of D‐β‐hydroxybutyrate dehydrogenase in rat liver and brain

Zhang, W., Churchill, S. A., & Churchill, P. F. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81720-x · Cited by 8 · see citing works

Untitled work

(1999) · doi:10.1002/(sici)1097-4547(19990715)57:2

Exosomes as drug delivery vehicles for Parkinson’s disease therapy

Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · see citing works

Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics

Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,617 · see citing works

A microbial polyhydroxyalkanoates (PHA) based bio- and materials industry

Chen, G. (2009) · Chemical Society Reviews · doi:10.1039/b812677c · Cited by 1,302 · see citing works

Mitochondrial dysfunction: mechanisms and advances in therapy

Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,274 · see citing works

Protocol for the MPTP mouse model of Parkinson's disease

Jackson-Lewis, V. R., & Przedborski, S. (2007) · Nature Protocols · doi:10.1038/nprot.2006.342 · Cited by 1,118 · see citing works

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003 · see citing works

Ketone bodies as signaling metabolites

Newman, J. C., & Verdin, E. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.002 · Cited by 966 · see citing works

NAD+ in Brain Aging and Neurodegenerative Disorders

Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790 · see citing works

Brain metabolism in health, aging, and neurodegeneration

Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752 · see citing works

Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate

Sleiman, S. F., Henry, J., Al-Haddad, R., El Hayek, L., Abou Haidar, E., Stringer, T., Ulja, D., Karuppagounder, S. S., Holson, E. B., Ratan, R. R., et al. (2016) · eLife · doi:10.7554/elife.15092 · Cited by 810 · see citing works

Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738 · see citing works

Intermittent metabolic switching, neuroplasticity and brain health

Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M., & Cheng, A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.156 · Cited by 624 · see citing works

The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies

Maalouf, M., Rho, J. M., & Mattson, M. P. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 575 · see citing works

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · see citing works

A Guide to Neurotoxic Animal Models of Parkinson's Disease

Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483 · see citing works

DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase

Andrés‐Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B., Greco, T. M., Thomas, B., Ko, H. S., Sasaki, M., Ischiropoulos, H., Przedborski, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703219104 · Cited by 478 · see citing works

Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation

Maalouf, M., Sullivan, P. G., Davis, L. M., Kim, D., & Rho, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.065 · Cited by 477 · see citing works

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 450 · see citing works

The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages

Rahman, M., Muhammad, S., Khan, M. A., Chen, H., Ridder, D. A., Müller‐Fielitz, H., Pokorná, B., Vollbrandt, T., Stölting, I., Nadrowitz, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms4944 · Cited by 430 · see citing works

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease

Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Mosley, R. L. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 422 · see citing works

Energy metabolism in health and diseases

Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 438 · see citing works

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E., Mosley, R., & Gendelman, H. E. (2010) · Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 391 · see citing works

Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations

Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 412 · see citing works

Neuroprotective and disease-modifying effects of the ketogenic diet

Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445 · see citing works

Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases

Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 372 · see citing works

Ketone Bodies as a Therapeutic for Alzheimer's Disease

Henderson, S. T. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.004 · Cited by 323 · see citing works

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

Benner, E. J., Mosley, R. L., Destache, C. J., Lewis, T. B., Jackson-Lewis, V. R., Gorantla, S., Nemachek, C., Green, S. R., Przedborski, S., & Gendelman, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400569101 · Cited by 321 · see citing works

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage

Perier, C., Tieu, K., Guégan, C., Caspersen, C. S., Jackson-Lewis, V. R., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308 · see citing works

Mitochondrial Biology and Parkinson's DiseasePreprint

Perier, C., & Vila, M. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009332 · Cited by 304 · see citing works

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Béard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 309 · see citing works

Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)

Włodarek, D. (2019) · Nutrients · doi:10.3390/nu11010169 · Cited by 301 · see citing works

Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study

VanItallie, T. B., Nonas, C., Rocco, A. D., Boyar, K. L., Hyams, K., & Heymsfield, S. B. (2005) · Neurology · doi:10.1212/01.wnl.0000152046.11390.45 · Cited by 300 · see citing works

Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial

Phillips, M. C. L., Murtagh, D. K. J., Gilbertson, L. J., Asztely, F. J. S., & Lynch, C. D. P. (2018) · Movement Disorders · doi:10.1002/mds.27390 · Cited by 292 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease

Przedborski, S., Tieu, K., Perier, C., & Vila, M. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041771.66775.d5 · Cited by 289 · see citing works

A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis

Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286 · see citing works

Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice

Choi, D., Pennathur, S., Perier, C., Tieu, K., Teismann, P., Wu, D.-C., Jackson-Lewis, V. R., Vila, M., Vonsattel, J., Heinecke, J. W., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0970-05.2005 · Cited by 284 · see citing works

Ketogenic diets, mitochondria, and neurological diseases

Gano, L. B., Patel, M., & Rho, J. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r048975 · Cited by 279 · see citing works

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms

Fu, S., Wang, J., Xue, W.-J., Liu, H., Liu, B.-R., Zeng, Y., Li, S., Huang, B., Lv, Q.-K., Wang, W., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0230-3 · Cited by 269 · see citing works

Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257 · see citing works

Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer’s Disease

Pinto, A., Bonucci, A., Maggi, E., Corsi, M., & Businaro, R. (2018) · Antioxidants · doi:10.3390/antiox7050063 · Cited by 259 · see citing works

Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance

Raefsky, S. M., & Mattson, M. P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.045 · Cited by 274 · see citing works

Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of α-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans

Ved, R., Saha, S., Westlund, B., Perier, C., Griffin, L. B., Sluder, A. E., Hoener, M. C., Rodrigues, C. M. P., Alfonso, A., Steer, C. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505910200 · Cited by 256 · see citing works

ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction

Takuma, K., Yao, J., Huang, J., Xu, H., Chen, X., Luddy, J. S., Trillat, A., Stern, D. M., Arancio, O., & Yan, S. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2582fje · Cited by 254 · see citing works

The ketogenic diet: Uses in epilepsy and other neurologic illnesses

Barañano, K. W., & Hartman, A. L. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0043-8 · Cited by 239 · see citing works

Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: “Mitohormesis” for health and vitality

Tapia, P. C. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.09.009 · Cited by 239 · see citing works

β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms

Achanta, L. B., & Rae, C. D. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2099-2 · Cited by 239 · see citing works

Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP + , or paraquat

Choi, W.-S., Kruse, S. E., Palmiter, R. D., & Xia, Z. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807581105 · Cited by 236 · see citing works

Obesity and aging: Molecular mechanisms and therapeutic approaches

Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 240 · see citing works

Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo

Rappold, P. M., Cui, M., Grima, J. C., Fan, R. Z., Bentley, K. L. D. M., Chen, L., Zhuang, X., Bowers, W. J., & Tieu, K. (2014) · Nature Communications · doi:10.1038/ncomms6244 · Cited by 227 · see citing works

Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury

Prins, M. L. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600543 · Cited by 229 · see citing works

Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives

Qiu, H., Novikov, A., & Vallon, V. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2886 · Cited by 226 · see citing works

Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases

Paoli, A., Bianco, A., Damiani, E., & Bosco, G. (2014) · BioMed Research International · doi:10.1155/2014/474296 · Cited by 221 · see citing works

Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease

Dedkova, E. N., & Blatter, L. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00260 · Cited by 220 · see citing works

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

Mor, D. E., Tsika, E., Mazzulli, J. R., Gould, N. S., Kim, H., Daniels, M. J., Doshi, S., Gupta, P., Grossman, J., Tan, V. X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4641 · Cited by 219 · see citing works

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases

Yao, W., Hu, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01918-w · Cited by 229 · see citing works

The Role of Ketogenic Diet in the Treatment of Neurological Diseases

Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215 · see citing works

Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses

Yamanashi, T., Iwata, M., Kamiya, N., Tsunetomi, K., Kajitani, N., Wada, N., Iitsuka, T., Yamauchi, T., Miura, A., Pu, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08055-1 · Cited by 214 · see citing works

The Ketogenic diet: from molecular mechanisms to clinical effects

(2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.10.003 · Cited by 213 · see citing works

Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity

Greco, T., Glenn, T. C., Hovda, D. A., & Prins, M. L. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15610584 · Cited by 210 · see citing works

Perturbations in Mitochondrial Dynamics Induced by Human Mutant PINK1 Can Be Rescued by the Mitochondrial Division Inhibitor mdivi-1

Cui, M., Tang, X., Christian, W. V., Yoon, Y., & Tieu, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066662 · Cited by 205 · see citing works

D-beta-hydroxybutyrate extends lifespan in C. elegans

Edwards, C., Canfield, J., Copes, N., Rehan, M., Lipps, D., & Bradshaw, P. C. (2014) · Aging · doi:10.18632/aging.100683 · Cited by 203 · see citing works

Ketone bodies are protective against oxidative stress in neocortical neurons

‍Kim, D. Y., Davis, L. M., Sullivan, P. G., Maalouf, M., Simeone, T. A., van Brederode, J. F. M., & Rho, J. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04483.x · Cited by 205 · see citing works

The ketogenic diet and brain metabolism of amino acids: Relationship to the anticonvulsant effect

Yudkoff, M., Daikhin, Y., Melø, T. M., Nissim, I., Sonnewald, U., & Nissim, I. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093722 · Cited by 202 · see citing works

Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms

Yang, H.-J., Wei, S., Zhu, F., Wu, J.-P., & Wang, Q. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00585 · Cited by 187 · see citing works

Nutritional Ketosis and Mitohormesis: Potential Implications for Mitochondrial Function and Human Health

Miller, V. J., Villamena, F. A., & Volek, J. S. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/5157645 · Cited by 200 · see citing works

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action

Fernando, W. M. A. D. B., Martins, I. J., Goozee, K. G., Brennan, C. S., Jayasena, V., & Martins, R. N. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001452 · Cited by 198 · see citing works

Ketone bodies in epilepsy

McNally, M. A., & Hartman, A. L. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07670.x · Cited by 194 · see citing works

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 205 · see citing works

Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease

Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190 · see citing works

Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions

Haces, M. L., Hernández‐Fonseca, K., Medina‐Campos, O. N., Montiel, T., Pedraza‐Chaverrí, J., & Massieu, L. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.029 · Cited by 187 · see citing works

Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders

Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182 · see citing works

A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 Axis

Hasan‐Olive, M. M., Lauritzen, K. H., Ali, M., Rasmussen, L. J., Storm‐Mathisen, J., & Bergersen, L. H. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2588-6 · Cited by 182 · see citing works

Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell

Gan, X., Huang, S., Wu, L., Wang, Y., Hu, G., Li, G., Zhang, H., Yu, H., Swerdlow, R. H., Chen, J. X., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.009 · Cited by 181 · see citing works

Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2

Graff, E. C., Fang, H., Wanders, D., & Judd, R. L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.001 · Cited by 181 · see citing works

Simvastatin Inhibits the Activation of p21rasand Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

Ghosh, A., Roy, A., Matras, J., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4144-09.2009 · Cited by 175 · see citing works

Clinical review: Ketones and brain injury

White, H. T., & Venkatesh, B. (2011) · Critical Care · doi:10.1186/cc10020 · Cited by 175 · see citing works

Fasting is neuroprotective following traumatic brain injury

Davis, L. M., Pauly, J. R., Readnower, R. D., Rho, J. M., & Sullivan, P. G. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21628 · Cited by 172 · see citing works

Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q₁₀

Moon, Y., Lee, K. H., Park, J., Geum, D., & Kim, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03112.x · Cited by 174 · see citing works

Drp1-Mediated Mitochondrial Abnormalities Link to Synaptic Injury in Diabetes Model

Huang, S., Wang, Y., Gan, X., Du, F., Zhong, C., Wu, L., Hu, G., Sosunov, A. A., McKhann, G. M., Yu, H., et al. (2014) · Diabetes · doi:10.2337/db14-0758 · Cited by 166 · see citing works

Novel ketone diet enhances physical and cognitive performance

Murray, A. J., Knight, N. S., Cole, M. A., Cochlin, L. E., Carter, E., Tchabanenko, K., Pichulik, T., Gulston, M. K., Atherton, H. J., Schroeder, M., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600773r · Cited by 165 · see citing works

Pyruvate dehydrogenase complex: Metabolic link to ischemic brain injury and target of oxidative stress

Martin, E., Rosenthal, R. E., & Fiskum, G. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20293 · Cited by 165 · see citing works

Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism

Anandhan, A., Jacome, M. S., Lei, S., Hernández-Franco, P., Pappa, A., Panayiotidis, M. I., Powers, R., & Franco, R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.009 · Cited by 161 · see citing works

Hypometabolism as a therapeutic target in Alzheimer's disease

Costantini, L. C., Barr, L. J., Vogel, J. L., & Henderson, S. T. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s16 · Cited by 162 · see citing works

On the Run for Hippocampal PlasticityPreprint

Cooper, C. P., Moon, H. Y., & van Praag, H. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029736 · Cited by 160 · see citing works

Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity

Yang, X., & Cheng, B. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9336-y · Cited by 159 · see citing works

Lifelong brain health is a lifelong challenge: From evolutionary principles to empirical evidence

Mattson, M. P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.011 · Cited by 155 · see citing works

Microglia-Specific Metabolic Changes in Neurodegeneration

Aldana, B. I. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.03.006 · Cited by 153 · see citing works

Ketogenic diets: from cancer to mitochondrial diseases and beyond

Branco, A. F., Ferreira, A., Simões, R. F., Novais, S. M., Zehowski, C., Cope, E., Silva, A. M., Pereira, D. J., Sardão, V. A., & Cunha‐Oliveira, T. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12591 · Cited by 152 · see citing works

Implications of the Gut Microbiome in Parkinson's Disease

Elfil, M., Kamel, S., Kandil, M. A., Koo, B. B., & Schaefer, S. M. (2020) · Movement Disorders · doi:10.1002/mds.28004 · Cited by 157 · see citing works

Microbial production and applications of chiral hydroxyalkanoates

Chen, G., & Wu, Q. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1917-2 · Cited by 150 · see citing works

Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester

Hashim, S. A., & VanItallie, T. B. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046599 · Cited by 151 · see citing works

β-Hydroxybutyrate Prevents Vascular Senescence through hnRNP A1-Mediated Upregulation of Oct4

Han, Y., Bédarida, T., Ding, Y., Somba, B. K., Lu, Q., Wang, Q., Song, P., & Zou, M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.036 · Cited by 148 · see citing works

Diet in Parkinson’s Disease: Critical Role for the Microbiome

Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145 · see citing works

Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease

Roy, A., Ghosh, A., Jana, A., Liu, X., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038113 · Cited by 145 · see citing works

Proteasome inhibition and Parkinson's disease modeling

Bové, J., Zhou, C. H., Jackson-Lewis, V. R., Taylor, J. P., Chu, Y., Rideout, H. J., Wu, D.-C., Kordower, J. H., Petrucelli, L., & Przedborski, S. (2006) · Annals of Neurology · doi:10.1002/ana.20937 · Cited by 143 · see citing works

Neuroketotherapeutics: A modern review of a century-old therapy

Koppel, S. J., & Swerdlow, R. H. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.019 · Cited by 140 · see citing works

Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder

Khan, A. U., Akram, M., Daniyal, M., & Zainab, R. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1486837 · Cited by 145 · see citing works

d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 531 · see citing works

D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease

Imamura, K., Takeshima, T., Kashiwaya, Y., Nakaso, K., & Nakashima, K. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21021 · Cited by 99 · see citing works

The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease

Norwitz, N. G., Hu, M. T., & Clarke, K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00063 · Cited by 110 · see citing works

Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson’s Disease

Kim, Y., Choi, S. Y., Hwang, O., & Lee, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03017-9 · Cited by 14 · see citing works

β-Hydroxybutyrate alleviates pyroptosis in MPP+/MPTP-induced Parkinson’s disease models via inhibiting STAT3/NLRP3/GSDMD pathway

Jiang, Z., Yin, X., Wang, M., Wang, Y., Li, F., Gao, Y., Han, G., Gao, Z., & Wang, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109451 · Cited by 61 · see citing works